Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant tumor that arises from the bone. It is characterized by the presence of an area of high grade sarcoma in an otherwise typical giant cell tumor (primary malignancy in giant cell tumor), or the presence of sarcoma in which the pre-existing giant cell tumor may or may not be apparent (secondary malignancy in giant cell tumor).
Biomarker and diagnostic research for malignancy in giant cell tumor of bone has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy, other interventions, and biologic therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
162 publications have been identified in PubMed for malignancy in giant cell tumor of bone. Research spans Review / Meta-Analysis (34%), Case Report / Case Series (23%), and Epidemiology / Natural History (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 55 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:51 AM UTC
Patient case studies | 37 | 23% |
Disease patterns and progression | 22 | 14% |
Laboratory research | 17 | 10% |
Clinical study results | 16 | 10% |
Testing and diagnosis research | 12 | 7% |
New treatment approaches | 3 | 2% |
Yuan Y (2026). [PMID: 41922828](https://pubmed.ncbi.nlm.nih.gov/41922828/). *Cancer Metastasis Rev*. [Review / Meta-Analysis]
Daher M (2026). [PMID: 41662446](https://pubmed.ncbi.nlm.nih.gov/41662446/). *J Bone Joint Surg Am*. [Review / Meta-Analysis]
Zhao Z (2026). [PMID: 42030226](https://pubmed.ncbi.nlm.nih.gov/42030226/). *Am J Case Rep*. [Review / Meta-Analysis]
Atasoy D (2026). [PMID: 41622468](https://pubmed.ncbi.nlm.nih.gov/41622468/). *The American journal of surgical pathology*. [Diagnostic / Biomarker]
Verbo A (2026). [PMID: 41608553](https://pubmed.ncbi.nlm.nih.gov/41608553/). *Journal of surgical case reports*. [Case Report / Case Series]
Fujita M (2026). [PMID: 41396375](https://pubmed.ncbi.nlm.nih.gov/41396375/). *Oral radiology*. [Case Report / Case Series]
Satala CB (2026). [PMID: 41718306](https://pubmed.ncbi.nlm.nih.gov/41718306/). *Reports (MDPI)*. [Case Report / Case Series]
da Silva Barros CC (2026). [PMID: 41936457](https://pubmed.ncbi.nlm.nih.gov/41936457/). *Cancer Med*. [Basic Science / Preclinical]
Delmonte Moreira F (2026). [PMID: 41355452](https://pubmed.ncbi.nlm.nih.gov/41355452/). *Foot & ankle international*. [Review / Meta-Analysis]
Lu S (2026). [PMID: 41628228](https://pubmed.ncbi.nlm.nih.gov/41628228/). *PLoS One*. [Case Report / Case Series]